Skip to main content

Michael Mulvihill, MD

House Staff
Start Year: 
Pomona College
Medical School: 
Duke University School of Medicine

Clinical and Research Interests

Clinically, I am interested in the role of surgery in the management of end-stage heart and lung disease. I participate in health services research in which we examine the efficiency of and disparities in the allocation of thoracic allografts to those awaiting heart and lung transplantation. My basic science work has centered on the energetics associated with primary graft dysfunction following heart and lung transplantation, along with novel immunosuppression strategies to prevent allograft rejection.  

What were you looking for in a residency program?

Excellence in clinical training, a team of co-residents interested in supporting one another

What are the strengths of the Duke program?

Excellent clinical training, unparalleled research program, great team of residents

What advice do you have for incoming interns?

We are here for you!

What do you like best about living in Durham and the Triangle?

Brumley Nature Preserve is probably my favorite place to sneak away for cyclocross and trail running.

What do you like to do outside of Duke?

Maya is the new addition to our family. Most of the time outside of Duke we are just trying to keep up with her!

Honors and Awards

  • Research fellowship funded by NIH-NHLBI F32, grants from AST and SCORES


Ezekian, Jordan E., Michael S. Mulvihill, Brian Ezekian, Morgan L. Cox, Sonya Kirmani, and Kevin D. Hill. “Decline of increased risk donor offers increases waitlist mortality in paediatric heart transplantation.” Cardiol Young 31, no. 8 (August 2021): 1228–37.

Full Text

Choi, Ashley Y., Oliver K. Jawitz, Vignesh Raman, Michael S. Mulvihill, Samantha E. Halpern, Yaron D. Barac, Jacob A. Klapper, and Matthew G. Hartwig. “Predictors of nonuse of donation after circulatory death lung allografts.” J Thorac Cardiovasc Surg 161, no. 2 (February 2021): 458-466.e3.

Full Text

Esposito, V. R., B. A. Yerokun, M. S. Mulvihill, M. L. Cox, B. Y. Andrew, C. J. Yang, A. Y. Choi, et al. “Resection of the irradiated esophagus: the impact of lymph node yield on survival.” Dis Esophagus 33, no. 10 (October 12, 2020).

Full Text

Barac, Yaron D., Mike S. Mulvihill, Oliver Jawitz, Jacob Klapper, John Haney, Mani Daneshmand, Basil Nasir, Dongfeng Chen, Carmelo A. Milano, and Matthew G. Hartwig. “Increased Calculated Panel Reactive Antigen Is Associated With Increased Waitlist Time and Mortality in Lung Transplantation.” Ann Thorac Surg 110, no. 2 (August 2020): 414–23.

Full Text

Choi, Ashley Y., Michael S. Mulvihill, Hui-Jie Lee, Congwen Zhao, Maragatha Kuchibhatla, Jacob N. Schroder, Chetan B. Patel, Christopher B. Granger, and Matthew G. Hartwig. “Transplant Center Variability in Organ Offer Acceptance and Mortality Among US Patients on the Heart Transplant Waitlist.” Jama Cardiol 5, no. 6 (June 1, 2020): 660–68.

Full Text

Mulvihill, Michael S., Hui J. Lee, Jeremy Weber, Ashley Y. Choi, Morgan L. Cox, Babatunde A. Yerokun, Muath A. Bishawi, Jacob Klapper, Maragatha Kuchibhatla, and Matthew G. Hartwig. “Variability in donor organ offer acceptance and lung transplantation survival.” J Heart Lung Transplant 39, no. 4 (April 2020): 353–62.

Full Text

Osho, Asishana A., Muath M. Bishawi, Michael S. Mulvihill, Andrea L. Axtell, Sameer A. Hirji, Philip J. Spencer, Elbert E. Heng, et al. “Failure to Rescue Contributes to Center-Level Differences in Mortality After Lung Transplantation.” Ann Thorac Surg 109, no. 1 (January 2020): 218–24.

Full Text

Ezekian, Brian, Paul M. Schroder, Michael S. Mulvihill, Andrew Barbas, Bradley Collins, Kyle Freischlag, Janghoon Yoon, et al. “Pretransplant Desensitization with Costimulation Blockade and Proteasome Inhibitor Reduces DSA and Delays Antibody-Mediated Rejection in Highly Sensitized Nonhuman Primate Kidney Transplant Recipients.” J Am Soc Nephrol 30, no. 12 (December 2019): 2399–2411.

Full Text

Choi, Ashley Y., Michael S. Mulvihill, Hui-Jie Lee, Congwen Zhao, Maragatha Kuchibhatla, Christopher B. Granger, and Matthew G. Hartwig. “Heart Transplant Candidates Listed at Low First-Rank Organ Acceptance Rate Centers Are More Likely to Die Waiting.” In Circulation, Vol. 140, 2019.